The interface of psychiatry and COVID-19: Challenges for management of psychiatric patients | [Pakistan Journal of Medical Sciences • 2020]

Author(s):

1. Afzal Javed: Asian Federation of Psychiatric Associations & Elect-World Psychiatric Association & Pakistan Psychiatric Research Centre, Fountain House, Lahore, Pakistan

2. E. Mohandas: Pharmaco-Psychiatry Section, World Psychiatric Association dent - Indian Psychiatric Society, Sun Medical and Research Centre, Trichur, Kerala, India

3. Avinash De Sousa: Dept. of Psychiatry, Lokmanya Tilak Municipal Medical College,Mumbai, India.

Abstract:

COVID-19 is a viral infection that has multisystemic physical and psychological complications. The following paper looks at the various challenges seen while treating psychiatric patients during the COVID pandemic. There is a need for physician to be aware of the drug interactions between psychiatric medications and the medications used routinely in the management of COVID. There is also the concern of psychiatric side effects of medications used to manage COVID and medical complications caused by some side effects of psychiatric drugs. The telepsychiatry and telemedicine paradigm has made it mandatory for physicians to be vigilant of the same.

Page(s): 1133-1136

DOI: DOI not available

Published: Journal: Pakistan Journal of Medical Sciences, Volume: 36, Issue: 5, Year: 2020

Keywords:

COVID , telepsychiatry , psychiatric medication

References:

References are not available for this document.

Citations

Citations are not available for this document.

Citations

Downloads

Views